S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0070
-0.0002 (-2.78%)
Sep 2, 2026, 5:29 PM CET
S2Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 14.9 | 16.13 | 14.68 | 7.72 | 6.16 | 10.63 |
Other Revenue | -0.71 | -0 | - | - | - | - |
| 14.19 | 16.13 | 14.68 | 7.72 | 6.16 | 10.63 | |
Revenue Growth | -9.82% | 9.90% | 90.03% | 25.39% | -42.08% | -61.98% |
Cost of Revenue | 1.72 | 2.09 | 0.77 | 2.69 | 0.99 | 3.54 |
Gross Profit | 12.47 | 14.04 | 13.91 | 5.04 | 5.17 | 7.1 |
Selling, General & Admin | 14.99 | 15.45 | 14.99 | 19.14 | 31.54 | 25.54 |
Other Operating Expenses | -1.78 | -0.02 | -7.22 | -0.57 | -0.61 | -0.1 |
Operating Expenses | 14.4 | 16.71 | 9.08 | 20.3 | 32.85 | 26.93 |
Operating Income | -1.93 | -2.66 | 4.83 | -15.26 | -27.69 | -19.84 |
Interest Expense | - | -0.01 | -0.02 | -7.44 | -1.77 | -0.24 |
Interest & Investment Income | 0.03 | 0 | 0 | 0 | - | - |
Other Non Operating Income (Expenses) | 0 | 0 | - | - | - | - |
EBT Excluding Unusual Items | -1.9 | -2.67 | 4.81 | -22.71 | -29.46 | -20.08 |
Gain (Loss) on Sale of Investments | -7.42 | -7.42 | - | - | - | - |
Pretax Income | -9.32 | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income | -10.07 | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income to Common | -10.07 | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 857 | 560 | 121 | 24 | 15 |
Shares Outstanding (Diluted) | - | 857 | 560 | 121 | 24 | 15 |
Shares Change | - | 53.03% | 360.86% | 411.02% | 60.30% | 26.41% |
EPS (Basic) | - | -0.01 | 0.01 | -0.19 | -1.24 | -1.35 |
EPS (Diluted) | - | -0.01 | 0.01 | -0.19 | -1.24 | -1.35 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.44 | 0.68 | 5.03 | -16.52 | -28.34 | -19.85 |
Free Cash Flow Per Share | - | 0.00 | 0.01 | -0.14 | -1.19 | -1.34 |
Gross Margin | 87.87% | 87.06% | 94.79% | 65.22% | 83.86% | 66.74% |
Operating Margin | -13.63% | -16.51% | 32.89% | -197.63% | -449.53% | -186.54% |
Profit Margin | -70.98% | -62.58% | 32.78% | -294.00% | -478.23% | -188.83% |
Free Cash Flow Margin | -3.14% | 4.19% | 34.28% | -213.89% | -460.08% | -186.70% |
EBITDA | -1.36 | -2 | 5.52 | -14.14 | -26.37 | -18.73 |
EBITDA Margin | -9.59% | -12.43% | 37.61% | -183.02% | - | -176.11% |
D&A For EBITDA | 0.57 | 0.66 | 0.69 | 1.13 | 1.32 | 1.11 |
EBIT | -1.93 | -2.66 | 4.83 | -15.26 | -27.69 | -19.84 |
EBIT Margin | -13.63% | -16.51% | 32.89% | -197.63% | - | -186.54% |
Revenue as Reported | 16.73 | 16.89 | 22.33 | 8.45 | 8.93 | 11.5 |